Global Cord Blood Corporation (CO) Misses Q2 EPS by 5c, Revenues Miss

Global Cord Blood Corporation (NYSE: CO) reported Q2 EPS of $0.08, $0.05 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $35.98 million versus the consensus estimate of $39.36 million.

"We are glad to see the new subscriber number increase by 11.2% in the second quarter from the previous quarter, which demonstrates the success of the measures we took under current market conditions. As we continue to execute on our strategies, we remain cautiously optimistic about our growth prospects in the second half of the year, which are supported by the Chinese government announcing business-friendly policies amid escalating trade tensions between the U.S. and China." said Ms. Ting Zheng, Chairperson and Chief Executive Officer of GCBC. "While keeping our focus on nurturing and penetrating existing domestic markets, we will continue to explore potential development opportunities to expand revenue sources or save costs in order to consolidate our position as the industry leader."

For earnings history and earnings-related data on Global Cord Blood Corporation (CO) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02